The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing
Natalie E. Nieuwenhuizen(Max Planck Institute for Infection Biology), Stefan H. E. Kaufmann(Max Planck Institute for Infection Biology)
Cited by 179
Related Papers
Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis
|Nature Medicine|2003|539
Differential Organization of the Local Immune Response in Patients with Active Cavitary Tuberculosis or with Nonprogressive Tuberculoma
|The Journal of Infectious Diseases|2005|134
Next-Generation Vaccines Based on Bacille Calmette–Guérin
|Frontiers in Immunology|2018|122